Anti-breast cancer potential of quercetin via the AkT/AMPK/mammalian target of rapamycin (mTOR) signaling cascade

PLoS ONE

Volumn 11, Issue 6, 2016, Pages

  Rivera, Amilcar Rivera ^a   Castillo Pichardo, Linette ^a,b   Gerena, Yamil ^a   Dharmawardhane, Suranganie ^a  

^a UNIVERSITY OF PUERTO RICO SCHOOL OF MEDICINE   (Puerto Rico)

^b SCHOOL OF MEDICINE   (Puerto Rico)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CATECHIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; PROTEIN KINASE B; QUERCETIN; RESVERATROL; STILBENE DERIVATIVE; TARGET OF RAPAMYCIN KINASE;

ANIMAL; BREAST; BREAST NEOPLASMS; CELL CYCLE; CELL PROLIFERATION; CHEMISTRY; DRUG EFFECTS; FEMALE; HUMAN; METABOLISM; NEOPLASM METASTASIS; NUDE MOUSE; PATHOLOGY; SCID MOUSE; SIGNAL TRANSDUCTION; TUMOR CELL LINE; VITIS;

AMP-ACTIVATED PROTEIN KINASES; ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; BREAST; BREAST NEOPLASMS; CATECHIN; CELL CYCLE; CELL LINE, TUMOR; CELL PROLIFERATION; FEMALE; HUMANS; MICE, NUDE; MICE, SCID; NEOPLASM METASTASIS; PROTO-ONCOGENE PROTEINS C-AKT; QUERCETIN; SIGNAL TRANSDUCTION; STILBENES; TOR SERINE-THREONINE KINASES; VITIS;

EID: 85019227198     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0157251     Document Type: Article

References (54)

1. Lu J, Steeg PS, Price JE, Krishnamurthy S, Mani SA, Reuben J, et al. Breast cancer metastasis: challenges and opportunities. Cancer Res 2009 Jun 15; 69(12):4951-3. doi: 10.1158/0008-5472.CAN-09-0099 PMID: 19470768
2. Zhou H, Huang S. mTOR Signaling in cancer cell motility and tumor metastasis. Crit Rev Eukaryot Gene Expr 2010; 20(1):1-16. PMID: 20528734
3. Laplante M, Sabatini DM. mTOR signaling in growth control and disease. Cell 2012 Apr 13; 149 (2):274-93. doi: 10.1016/j.cell.2012.03.017 PMID: 22500797
4. Courtney KD, Corcoran RB, Engelman JA. The PI3K pathway as drug target in human cancer. J Clin Oncol 2010 Feb 20; 28(6):1075-83. doi: 10.1200/JCO.2009.25.3641 PMID: 20085938
5. Altomare DA, Testa JR. Perturbations of the AKT signaling pathway in human cancer. Oncogene 2005 Nov 14; 24(50):7455-64. PMID: 16288292
6. Li W, Saud SM, Young MR, Chen G, Hua B. Targeting AMPK for cancer prevention and treatment. Oncotarget 2015 Apr 10; 6(10):7365-78. PMID: 25812084
7. Gwinn DM, Shackelford DB, Egan DF, Mihaylova MM, Mery A, Vasquez DS, et al. AMPK phosphorylation of raptor mediates a metabolic checkpoint. Mol Cell 2008 Apr 25; 30(2):214-26. doi: 10.1016/j. molcel.2008.03.003 PMID: 18439900
8. Guo D, Hildebrandt IJ, Prins RM, Soto H, Mazzotta MM, Dang J, et al. The AMPK agonist AICAR inhibits the growth of EGFRvIII-expressing glioblastomas by inhibiting lipogenesis. Proc Natl Acad Sci U S A 2009 Aug 4; 106(31):12932-7. doi: 10.1073/pnas.0906606106 PMID: 19625624
9. Bodmer M, Meier C, Krahenbuhl S, Jick SS, Meier CR. Long-term metformin use is associated with decreased risk of breast cancer. Diabetes Care 2010 Jun; 33(6):1304-8. doi: 10.2337/dc09-1791 PMID: 20299480
10. van der Heijden MS, Bernards R. Inhibition of the PI3K pathway: hope we can believe in? Clin Cancer Res 2010 Jun 15; 16(12):3094-9. doi: 10.1158/1078-0432.CCR-09-3004 PMID: 20400520
11. Castillo-Pichardo L, Dharmawardhane SF. Grape polyphenols inhibit akt/mammalian target of rapamycin signaling and potentiate the effects of gefitinib in breast cancer. Nutr Cancer 2012 Oct; 64(7):1058-69. doi: 10.1080/01635581.2012.716898 PMID: 23061908
12. Bonofiglio D, Giordano C, De AF, Lanzino M, Ando S. Natural Products as Promising Antitumoral Agents in Breast Cancer: Mechanisms of Action and Molecular Targets. Mini Rev Med Chem 2016; 16 (8):596-604. PMID: 26156544
13. Aggarwal BB, Shishodia S. Molecular targets of dietary agents for prevention and therapy of cancer. Biochem Pharmacol 2006 May 14; 71(10):1397-421. PMID: 16563357
14. Levi F, Pasche C, Lucchini F, Ghidoni R, Ferraroni M, La Vecchia C. Resveratrol and breast cancer risk. Eur J Cancer Prev 2005 Apr; 14(2):139-42. PMID: 15785317
15. Morre DM, Morre DJ. Anticancer activity of grape and grape skin extracts alone and combined with green tea infusions. Cancer Lett 2005 Aug 26.
16. Martinez C, Vicente V, Yanez J, Alcaraz M, Castells MT, Canteras M, et al. The effect of the flavonoid diosmin, grape seed extract and red wine on the pulmonary metastatic B16F10 melanoma. Histol Histopathol 2005 Oct; 20(4):1121-9. PMID: 16136495
17. Singletary KW, Stansbury MJ, Giusti M, van Breemen RB, Wallig M, Rimando A. Inhibition of rat mammary tumorigenesis by concord grape juice constituents. J Agric Food Chem 2003 Dec 3; 51 (25):7280-6. PMID: 14640571
18. Singh RP, Tyagi AK, Dhanalakshmi S, Agarwal R, Agarwal C. Grape seed extract inhibits advanced human prostate tumor growth and angiogenesis and upregulates insulin-like growth factor binding protein-3. Int J Cancer 2004 Feb 20; 108(5):733-40. PMID: 14696100
19. Kim H, Hall P, Smith M, Kirk M, Prasain JK, Barnes S, et al. Chemoprevention by grape seed extract and genistein in carcinogen-induced mammary cancer in rats is diet dependent. J Nutr 2004 Dec; 134 (12 Suppl):3445S-52S. PMID: 15570052
20. Lu J, Zhang K, Chen S, Wen W. Grape seed extract inhibits VEGF expression via reducing HIF-1alpha protein expression. Carcinogenesis 2009 Apr; 30(4):636-44. doi: 10.1093/carcin/bgp009 PMID: 19131542
21. Damianaki A, Bakogeorgou E, Kampa M, Notas G, Hatzoglou A, Panagiotou S, et al. Potent inhibitory action of red wine polyphenols on human breast cancer cells. J Cell Biochem JID-8205768 2000 Jun 6; 78(3):429-41. PMID: 10861841
22. Nigdikar SV, Williams NR, Griffin BA, Howard AN. Consumption of red wine polyphenols reduces the susceptibility of low-density lipoproteins to oxidation in vivo. Am J Clin Nutr JID-0376027 1998 Aug; 68(2):258-65. PMID: 9701181
23. Faustino RS, Sobrattee S, Edel AL, Pierce GN. Comparative analysis of the phenolic content of selected Chilean, Canadian and American Merlot red wines. Mol Cell Biochem 2003 Jul; 249(1-2):11-9. PMID: 12956393
24. Castillo-Pichardo L, Martinez-Montemayor MM, Martinez JE, Wall KM, Cubano LA, Dharmawardhane S. Inhibition of mammary tumor growth and metastases to bone and liver by dietary grape polyphenols. Clin Exp Metastasis 2009; 26(6):505-16. doi: 10.1007/s10585-009-9250-2 PMID: 19294520
25. Schlachterman A, Valle F, Wall KM, Azios NG, Castillo L, Morell L, et al. Combined resveratrol, quercetin, and catechin treatment reduces breast tumor growth in a nude mouse model. Transl Oncol 2008 Mar; 1(1):19-27. PMID: 18607509
26. Walker EH, Pacold ME, Perisic O, Stephens L, Hawkins PT, Wymann MP, et al. Structural determinants of phosphoinositide 3-kinase inhibition by wortmannin, LY294002, quercetin, myricetin, and staurosporine. Mol Cell 2000 Oct; 6(4):909-19. PMID: 11090628
27. Weixel KM, Marciszyn A, Alzamora R, Li H, Fischer O, Edinger RS, et al. Resveratrol inhibits the epithelial sodium channel via phopshoinositides and AMP-activated protein kinase in kidney collecting duct cells. PLoS One 2013; 8(10):e78019. doi: 10.1371/journal.pone.0078019 PMID: 24205069
28. Bouvet M, Hoffman RM. Tumor imaging technologies in mouse models. Methods Mol Biol 2015; 1267:321-48. doi: 10.1007/978-1-4939-2297-0_16 PMID: 25636477
29. Kolker II, Stanislavskii ES, Zarubina EK, Grishina IA, Panova I. [Detection of antibodies to Pseudomonas aeruginosa in patients with burns]. Klin Med (Mosk) 1979 Nov; 57(11):77-81.
30. Castillo-Pichardo L, Cubano LA, Dharmawardhane S. Dietary grape polyphenol resveratrol increases mammary tumor growth and metastasis in immunocompromised mice. BMC Complement Altern Med 2013; 13:6. doi: 10.1186/1472-6882-13-6 PMID: 23298290
31. Larson AJ, Symons JD, Jalili T. Therapeutic potential of quercetin to decrease blood pressure: review of efficacy and mechanisms. Adv Nutr 2012 Jan; 3(1):39-46. doi: 10.3945/an.111.001271 PMID: 22332099
32. Sak K. Site-specific anticancer effects of dietary flavonoid quercetin. Nutr Cancer 2014; 66(2):177-93. doi: 10.1080/01635581.2014.864418 PMID: 24377461
33. Rein MJ, Renouf M, Cruz-Hernandez C, ctis-Goretta L, Thakkar SK, da Silva PM. Bioavailability of bio-active food compounds: a challenging journey to bioefficacy. Br J Clin Pharmacol 2013 Mar; 75 (3):588-602. doi: 10.1111/j.1365-2125.2012.04425.x PMID: 22897361
34. Scalbert A, Williamson G. Dietary intake and bioavailability of polyphenols. J Nutr 2000 Aug; 130(8S Suppl):2073S-85S. PMID: 10917926
35. Perez-Vizcaino F, Duarte J, Santos-Buelga C. The flavonoid paradox: conjugation and deconjugation as key steps for the biological activity of flavonoids. J Sci Food Agric 2012 Jul; 92(9):1822-5. doi: 10. 1002/jsfa.5697 PMID: 22555950
36. Hollman PC, van Trijp JM, Buysman MN, van der Gaag MS, Mengelers MJ, de Vries JH, et al. Relative bioavailability of the antioxidant flavonoid quercetin from various foods in man. FEBS Lett 1997 Nov 24; 418(1-2):152-6. PMID: 9414116
37. Ramos S. Cancer chemoprevention and chemotherapy: dietary polyphenols and signalling pathways. Mol Nutr Food Res 2008 May; 52(5):507-26. doi: 10.1002/mnfr.200700326 PMID: 18435439
38. Maurya AK, Vinayak M. Anticarcinogenic action of quercetin by downregulation of phosphatidylinositol 3-kinase (PI3K) and protein kinase C (PKC) via induction of p53 in hepatocellular carcinoma (HepG2) cell line. Mol Biol Rep 2015 Sep; 42(9):1419-29. doi: 10.1007/s11033-015-3921-7 PMID: 26311153
39. Maurya AK, Vinayak M. Modulation of PKC signaling and induction of apoptosis through suppression of reactive oxygen species and tumor necrosis factor receptor 1 (TNFR1): key role of quercetin in cancer prevention. Tumour Biol 2015 Nov; 36(11):8913-24. doi: 10.1007/s13277-015-3634-5 PMID: 26076811
40. Ranganathan S, Halagowder D, Sivasithambaram ND. Quercetin Suppresses Twist to Induce Apoptosis in MCF-7 Breast Cancer Cells. PLoS One 2015; 10(10):e0141370. doi: 10.1371/journal.pone. 0141370 PMID: 26491966
41. Boly R, Gras T, Lamkami T, Guissou P, Serteyn D, Kiss R, et al. Quercetin inhibits a large panel of kinases implicated in cancer cell biology. Int J Oncol 2011 Mar; 38(3):833-42. doi: 10.3892/ijo.2010. 890 PMID: 21206969
42. Ferry DR, Smith A, Malkhandi J, Fyfe DW, de Takats PG, Anderson D, et al. Phase I clinical trial of the flavonoid quercetin: pharmacokinetics and evidence for in vivo tyrosine kinase inhibition. Clin Cancer Res 1996 Apr; 2(4):659-68. PMID: 9816216
43. Mihaylova MM, Shaw RJ. The AMPK signalling pathway coordinates cell growth, autophagy and metabolism. Nat Cell Biol 2011; 13(9):1016-23. doi: 10.1038/ncb2329 PMID: 21892142
44. Pratheeshkumar P, Budhraja A, Son YO, Wang X, Zhang Z, Ding S, et al. Quercetin inhibits angiogenesis mediated human prostate tumor growth by targeting V. PLoS One 2012; 7(10):e47516. doi: 10. 1371/journal.pone.0047516 PMID: 23094058
45. Tomatis L. Cell proliferation and carcinogenesis: a brief history and current view based on an IARC workshop report. International Agency for Research on Cancer. Environ Health Perspect 1993 Dec; 101 Suppl 5:149-51. PMID: 8013403
46. Deng XH, Song HY, Zhou YF, Yuan GY, Zheng FJ. Effects of quercetin on the proliferation of breast cancer cells and expression of survivin. Exp Ther Med 2013 Nov; 6(5):1155-8. PMID: 24223637
47. Casella ML, Parody JP, Ceballos MP, Quiroga AD, Ronco MT, Frances DE, et al. Quercetin prevents liver carcinogenesis by inducing cell cycle arrest, decreasing cell proliferation and enhancing apoptosis. Mol Nutr Food Res 2014 Feb; 58(2):289-300. doi: 10.1002/mnfr.201300362 PMID: 24124108
48. Quoc TL, Espinoza JL, Takami A, Nakao S. Resveratrol induces cell cycle arrest and apoptosis in malignant NK cells via JAK2/STAT3 pathway inhibition. PLoS One 2013; 8(1):e55183. doi: 10.1371/ journal.pone.0055183 PMID: 23372833
49. Vidya PR, Senthil MR, Maitreyi S, Ramalingam K, Karunagaran D, Nagini S. The flavonoid quercetin induces cell cycle arrest and mitochondria-mediated apoptosis in human cervical cancer (HeLa) cells through p53 induction and NF-kappaB inhibition. Eur J Pharmacol 2010 Dec 15; 649(1-3):84-91. doi: 10.1016/j.ejphar.2010.09.020 PMID: 20858478
50. Cao HH, Cheng CY, Su T, Fu XQ, Guo H, Li T, et al. Quercetin inhibits HGF/c-Met signaling and HGF-stimulated melanoma cell migration and invasion. Mol Cancer 2015; 14:103. doi: 10.1186/s12943-015-0367-4 PMID: 25971889
51. Mojsin M, Vicentic JM, Schwirtlich M, Topalovic V, Stevanovic M. Quercetin reduces pluripotency, migration and adhesion of human teratocarcinoma cell line NT2/D1 by inhibiting Wnt/beta-catenin signaling. Food Funct 2014 Oct; 5(10):2564-73. doi: 10.1039/c4fo00484a PMID: 25138740
52. Lin CW, Hou WC, Shen SC, Juan SH, Ko CH, Wang LM, et al. Quercetin inhibition of tumor invasion via suppressing PKC delta/ERK/AP-1-dependent matrix metalloproteinase-9 activation in breast carcinoma cells. Carcinogenesis 2008 Sep; 29(9):1807-15. doi: 10.1093/carcin/bgn162 PMID: 18628248
53. Michaud-Levesque J, Bousquet-Gagnon N, Beliveau R. Quercetin abrogates IL-6/STAT3 signaling and inhibits glioblastoma cell line growth and migration. Exp Cell Res 2012 May 1; 318(8):925-35. doi: 10.1016/j.yexcr.2012.02.017 PMID: 22394507
54. Lai WW, Hsu SC, Chueh FS, Chen YY, Yang JS, Lin JP, et al. Quercetin inhibits migration and invasion of SAS human oral cancer cells through inhibition of NF-kappaB and matrix metalloproteinase-2/-9 signaling pathways. Anticancer Res 2013 May; 33(5):1941-50. PMID: 23645742